官方服务：
资源简介：
PERTUZUMAB REGISTRY IN THE NEOADJUVANT SETTING FOR HER2-POSITIVE NON-METASTATIC BREAST CANCER IN AUSTRALIA (PERSIA)
应用场景：
创建时间：
2020-06-28
相关数据集
The use and impact of trastuzumab (Herceptin) for early and late stage HER-2 positive breast cancer in Australia
This project was established to conduct a long-term evaluation of the way in which trastuzumab (Herceptin) is used to treat early and late stage breast cancer in the real world clinical setting. Secon
DataCite Commons2022-07-26 更新80
Efficacy and Safety of Tislelizumab (BGB-A317) as Neo-Adjuvant Treatment in Patients With Colorectal Cancer
This study will evaluate the safety, and tolerability of neo-adjuvant treatment with tislelizumab in participants with early-stage (Stage II-III) Microsatellite Instability-High (MSI-H) or Mismatch Re
NIAID Data Ecosystem40
DataSheet1_Neoadjuvant leukocyte interleukin injection immunotherapy improves overall survival in low-risk locally advanced head and neck squamous cell carcinoma –the IT-MATTERS study.pdf
The randomized controlled pivotal phase 3 study evaluated efficacy and safety of neoadjuvant complex biologic, Leukocyte Interleukin Injection (LI), administered for 3 consecutive weeks pre-surgery, i
NIAID Data Ecosystem10
Effect of neoadjuvant chemotherapy combined with radiotherapy on postoperative lars of rectal cancer: a prospective cohort study
Interventions: neoadjuvant chemoradiotherapy:Nil;neoadjuvant chemotherapy:Nil Primary outcome(s): LARS score Study Design: Factorial
NIAID Data Ecosystem60
Prospective randomised clinical trial phase II: 5-fluorouracil/folinic acid (5-FU/FA) and irinotecan versus combination cepecitabin and irinotecan in patients with metastatic colorectal cancer as first line treatment
Study hypothesis: There will be no statistically significant differences in efficacy, safety and survival of XELIRI regimen compared to standard FOLFIRI regimen in neoadjuvant setting of patients with
NIAID Data Ecosystem20
